NoTimeRx: Engineering and Operating a Healthcare MSO Telehealth Platform

A non-clinical operating layer for telehealth and prescription coordination

One coordinated workflow with clearly separated responsibilities

Healthcare MSO and telehealth coordination platform

NoTimeRx

Provides the separate non-clinical operating structure and digital workflow that connects patients, independent licensed providers, e-prescribing technology, and participating compounding pharmacies.

Grant-supported platform engineering and operations

Biotica Consulting LLC

Biotica members provided grant financing for the initiative. Biotica engineers operate and maintain the NoTimeRx technology platform, coordinate third-party integrations, and support the non-clinical workflows that keep the platform functioning.

Clinical evaluation and prescribing

Independent licensed healthcare providers

Evaluate patients, apply professional judgment, determine whether treatment and a prescription are appropriate, and retain responsibility for clinical decisions and required patient verification.

Patient-specific compounding and dispensing

Participating 503A compounding pharmacies

Receive accepted prescriptions, compound and dispense patient-specific medications when legally and professionally appropriate, and remain responsible for pharmacy practice, product quality, counseling, fulfillment, and applicable state and federal requirements.

E-prescribing technology used by NoTimeRx

DoseSpot

Provides the certified e-prescribing platform used by authorized clinicians to create and securely transmit prescriptions, support pharmacy choice, and manage applicable prescribing workflows.

Underlying e-prescribing network via DoseSpot

Surescripts

Provides network infrastructure used for supported routing in the documented DoseSpot configuration. Surescripts validates applicable sender, recipient, and message rules, while clinical and data verification duties remain with the responsible providers and organizations.

From member-supported initiative to an operated platform workflow

1. 01
   2023

   NoTimeRx established its telehealth coordination model

   The company was founded around a platform model connecting patients, independent healthcare providers, and compounding pharmacies while maintaining a non-clinical coordination role.

2. 02
   Member grant

   Biotica Consulting members financed the initiative

   According to Biotica project records, members supplied grant funding that helped move the NoTimeRx concept into a buildable and operable technology program.

3. 03
   Platform operations

   Biotica engineers operated the MSO technology layer

   Engineering work supported the patient, provider, administrative, pharmacy, and third-party integration workflows needed to run the platform without moving clinical judgment into the MSO.

4. 04
   E-prescribing integration

   DoseSpot connected authorized prescribing to pharmacy routing

   The implementation uses DoseSpot for electronic prescribing and reports supported Surescripts routing to participating pharmacies, including selected 503A compounding pharmacies where the prescription and network conditions permit.

Questions the work was designed to answer

• How should an MSO support telehealth operations without crossing into clinical decision-making?
• Which patient, provider, prescription, pharmacy, payment, and support workflows belong in the platform?
• How should DoseSpot be integrated while preserving provider responsibility, pharmacy choice, and third-party network requirements?
• What controls are needed when electronic prescriptions are routed to participating 503A compounding pharmacies?
• How should financing, engineering operations, platform ownership, clinical care, and dispensing responsibilities be documented separately?
• Which privacy, security, audit, incident-response, vendor, and market requirements must be reviewed as the platform evolves?

What the documented operating model establishes

Controls that remain essential as the platform operates and scales

The project record is a development input, not permission to outrun the evidence. These are the next questions for direct testing and review.

• Are MSO, medical-practice, prescriber, pharmacy, vendor, and patient responsibilities current in every agreement and user-facing workflow?
• Do provider onboarding, licensure, identity proofing, authentication, scope-of-practice, and prescribing controls match each state and service line?
• Are pharmacy selection, anti-steering, prescription acceptance, fulfillment, shipping, counseling, and exception workflows documented and tested?
• Does each participating compounding pharmacy independently satisfy the requirements applicable to the prescription, patient, product, and destination state?
• Are privacy, security, access control, audit logging, consent, retention, incident response, business-associate, and vendor-management controls validated for the implemented data flows?
• Are DoseSpot, Surescripts, pharmacy, payment, messaging, and other vendor changes monitored through regression testing and operational release controls?
• Can the team reconcile prescription status, failures, changes, cancellations, pharmacy responses, support cases, and escalations without implying a guaranteed prescription or fulfillment outcome?
• Are the current NoTimeRx website, public disclosures, provider and pharmacy descriptions, and platform availability kept aligned with the actual operating model?